Suzhou, China

Yuhao Jin

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yuhao Jin: Innovator in Medical Biology from Suzhou

Introduction

Yuhao Jin is an accomplished inventor based in Suzhou, China, recognized for his contributions to the field of medical biology. With two significant patents to his name, Jin has made strides in developing innovative solutions to address critical healthcare challenges.

Latest Patents

Yuhao Jin's recent inventions include a patent focused on dimers formed by polypeptide chains. This dimer includes two polypeptide chains that comprise an antibody Fc subunit, featuring two or more immunoglobulin single variable domains (ISVDs). Notably, at least one ISVD is specific for PD-L1, while at least one other is specific for CTLA4.

His second notable patent encapsulates the intricacies of a PD-L1 blocking heavy-chain single-domain antibody, known as KN035. This invention includes a high-resolution crystal structure of the complex binding with PD-L1, as well as novel PD-L1 binding polypeptides or compounds developed from the crystal structure and their various applications.

Career Highlights

Throughout his career, Yuhao Jin has worked with reputable organizations, including Suzhou Alphamab Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. His work with these companies has significantly contributed to advancements in biopharmaceutical research and development.

Collaborations

Yuhao Jin has collaborated with esteemed colleagues, including Ting Xu and Xiaoxiao Wang. These collaborations have further enriched his research endeavors and have played a vital role in his innovative outputs.

Conclusion

In summary, Yuhao Jin stands out as a key figure in the realm of medical biology, with two impactful patents that showcase his inventive spirit. His work reflects a dedication to advancing medical research and developing innovative therapeutic solutions, which can potentially lead to improved healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…